Page last updated: 2024-10-30

mebendazole and Intellectual Disability

mebendazole has been researched along with Intellectual Disability in 1 studies

Mebendazole: A benzimidazole that acts by interfering with CARBOHYDRATE METABOLISM and inhibiting polymerization of MICROTUBULES.
mebendazole : A carbamate ester that is methyl 1H-benzimidazol-2-ylcarbamate substituted by a benzoyl group at position 5.

Intellectual Disability: Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual has an intellectual disability. IQ scores between 70 and 79 are in the borderline range. Scores below 67 are in the disabled range. (from Joynt, Clinical Neurology, 1992, Ch55, p28)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lormans, JA1
Wesel, AJ1
Vanparus, OF1

Other Studies

1 other study available for mebendazole and Intellectual Disability

ArticleYear
Mebendazole (R 17635) in enterobiasis. A clinical trial in mental retardates.
    Chemotherapy, 1975, Volume: 21, Issue:3-4

    Topics: Adolescent; Adult; Benzimidazoles; Child; Child, Preschool; Drug Evaluation; Enterobius; Female; Hum

1975